Hemiplegia and hemiparesis are the most common deficits caused by stroke.A randomized placebo-controlled trial was conducted at Chittagong Medical College Hospital from .One hundred and twenty eight patients, aged between 40-60 years with a diagnosis of acute ischaemic stroke who fulfilled criteria were selected for the study. Eligible patients were randomly assigned, Fluoxetine (20 mg once per day, orally) or placebo group for 3 months starting within 10 days after the onset of stroke. The primary outcome was the mean change in the Rivermead Mobility Index (RMI) score between inclusion (day 0) and day 90. RMI score was significantly changed from D 0 to D 90 in Fluoxetine group in comparison to placebo group (p<.001 and mean improvement of rmi score in days were significantly greater the fluoxetine group than placebo vs. treated with nearly times more likely to show motor nnt was patients acute ischaemic stroke deficit early administration physiotherapy enhanced recovery after months.>
| Autorius: | Mahfuzur Rahman, Mizanur Rahman, |
| Leidėjas: | LAP LAMBERT Academic Publishing |
| Išleidimo metai: | 2017 |
| Knygos puslapių skaičius: | 72 |
| ISBN-10: | 620201119X |
| ISBN-13: | 9786202011198 |
| Formatas: | Knyga minkštu viršeliu |
| Kalba: | Anglų |
Parašykite atsiliepimą apie „Fluoxetine after Acute Ischemic Stroke: Trial at Chittagong, Bangladesh“
